---
layout: post
title: "Starpharma's (ASX:SPL) VIRALEZE protects against Omicron variant"
external_url: https://www.asx.com.au/asxpdf/20220720/pdf/45c0g8x90dmfkg.pdf
featured: true
date: '2022-07-20 16:36:17 +1000'
year: "2022"
categories: 'linked'
ticker: 'ASX:SPL'
cash-tag: 'SPL'
tags:
- ASX
- SPL
- Starpharma
- COVID-19
- covid
- VIRALEZE
- SARS-CoV-2
- omicron
- biotech
- biotechnology
---

Biotechnology company, [Starpharma (ASX:SPL, OTCQX:SPHRY)](https://www2.asx.com.au/markets/company/SPL):

> announced new results demonstrating the high level of protection afforded by the VIRALEZE antiviral nasal spray against the highly infectious SARS-CoV-2 Omicron variant in vivo

<!--more-->

Shares up 1.52% on the announcement â€” has COVID lost its charm?
